No Detail Found!

Assessing white coat hypertension prevalence and anxiety levels using beck anxiety inventory: a study in outpatient settings

Author(s)
Muhammad Zohaib Rehman Khyber Medical College, University of Peshawar,,Pakistan
Khushbakht Noor Khyber Medical College, University of Peshawar,,Pakistan
Muhammad Shahid Bashir Khyber Medical College, University of Peshawar,,Pakistan
Muhammad Kamran Khyber Medical College, University of Peshawar,,Pakistan
Abstract
This study aimed to determine the prevalence of white coat hypertension (WCH) compared to home-based blood pressure (BP) measurements and assess anxiety levels among individuals with WCH using the Beck Anxiety Inventory. An observational cross-sectional study was conducted from March 2021 to April 2022 on individuals visiting the Outpatient Departments (OPDs) of Khyber Teaching Hospital, Peshawar. In-hospital and home BP recordings were performed, and anxiety levels were assessed using the Beck Anxiety Inventory. A sample size of 213 normotensive individuals was selected using a non-probability convenience sampling technique. Data were collected using structured questionnaires, analyzed using IBM SPSS version 26 and MS Excel 2019, and presented in tables and charts . Among the 213 respondents aged 14-67 years, comprising 164 (77%) males and 49 (23%) females, 22 (10.3%) exhibited BP readings above 140/90 in the OPD, indicative of WCH, while registering normal readings below 140/90 at home. The Beck anxiety index scores of these 22 individuals revealed varying degrees of anxiety, with 2 (9.1%) classified as Minimal, 6 (27.3%) as mild, 12 (54.5%) as Moderate, and 2 (9.1%) as severe anxiety. The prevalence of WCH underscores its clinical significance in predicting prehypertension, cardiovascular diseases (CVDs), and target organ damage. However, the propensity for labile BP in clinical environments may lead to misinterpretation, prompting unnecessary pharmacological interventions and exacerbating physical, mental, and financial distress for patients. Thus, widespread education on WCH among healthcare professionals and the public is crucial. Additionally, home-based BP measurements and ambulatory BP monitoring are advocated as preferred alternatives to mitigate the potential risks associated with WCH.
Publication Details
Page(s) 169-172
Published Journal: Pakistan Heart Journal, Volume: 57, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
Hypertension, Anxiety, WCH, White coat hypertension, blood pressure determination
References
.2013 .European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens, 31(9) : 1731-68.
Mancia G,Fagard R,Narkiewicz K,Redon J,Zanchetti A,Böhm M .2013 .ESH/ESC Guidelines for the management of arterial hypertension. Arterial Hypertension, 17(2) : 69-168.
Franklin SS,Thijs L,Asayama K,Li Y,Hansen TW,Boggia J .2016 .The cardiovascular risk of white-coat hypertension. J Am Coll Cardiol, 68(19) : 2033-43.
Dolan E,Stanton A,Atkins N,Den Hond E,Thijs L,McCormack P .2004 .Determinants of white-coat hypertension. , 9(6) : 307-9.
Jhalani J,Goyal T,Clemow L,Schwartz JE,Pickering TG,Gerin W. Anxiety .2005 .and outcome expectations predict the white-coat effect. , 10(6) : 317-9.
Verdecchia P,Palatini P,Schillaci G,Mormino P,Porcellati C,Pessina AC .2001 .Independent predictors of isolated clinic (white-coat') hypertension. J Hypertens, 19(6) : 1015-20.
Manios ED,Koroboki EA,Tsivgoulis GK,Spengos KM,Spiliopoulou IK,Brodie FG .2008 .Factors influencing white-coat effect. Am J Hypertens, 21(2) : 153-8.
Fisher M,Blackwell J,Saseen J. .2005 .Clinical inquiries. What is the best way to identify patients with white-coat hypertension? J Fam Pract. , 54(6) : 549-50.
Staessen JA,Asmar R,De Buyzere M,Imai Y,Parati G,Shimada K,Force II .2001 .Blood pressure measurement and cardiovacular outcome. , 6(6) : 355-70.
.2016 .3(1):e000406.. , : .
Dolan E,Stanton A,Atkins N,Den Hond E,Thijs L,McCormack P .2004 .Determinants of white-coat hypertension. , 9(6) : 307-9.
Gustavsen PH,Høegholm A,Bang LE,Kristensen KS .2003 .White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens, 17(12) : 811-7.
Aguirre-Ramos R,Trujillo-Hernández B,Huerta M,Trujillo X,Vásquez C,Millán-Guerrero RO .2002 .White-Coat Hypertension and Risk Factors in Recently Diagnosed Hypertensive Patients. Gac Med Mex, 138(4) : 319.
.2013 .European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens, 31(9) : 1731-68.
Godil SS,Tabani H,Khan AH,Almas A .2011 .White coat hypertension is not a benign entity: a cross-sectional study at a tertiary care hospital in Pakistan. J Pak Med Assoc, 61(9) : 938.
Shafique MN,RM SK,Razi MS,Muhammad S,Akhtar SH,Hussain M. .2020 .Cognitive behaviour therapy for white coat hypertension-causing latrophobia in adults: randomized controlled trial. J Paki Med Assoc, 70(9) : 1523-6.
0

Citations

0

Downloads

50

Views